Intervention Review

Dengzhanhua preparations for acute cerebral infarction

  1. Wenzhai Cao2,
  2. Weimin Liu3,
  3. Taixiang Wu4,
  4. Dechao Zhong2,
  5. Guanjian Liu1,*

Editorial Group: Cochrane Stroke Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 9 MAR 2008

DOI: 10.1002/14651858.CD005568.pub2


How to Cite

Cao W, Liu W, Wu T, Zhong D, Liu G. Dengzhanhua preparations for acute cerebral infarction. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD005568. DOI: 10.1002/14651858.CD005568.pub2.

Author Information

  1. 1

    West China Hospital, Sichuan University, Department of Evidence-Based Medicine and Clinical Epidemiology, Chengdu, Sichuan, China

  2. 2

    Zigong No. 1 People's Hospital, Department of Internal Medicine, Zigong, Sichuan Province, China

  3. 3

    China Academy of Traditional Chinese Medicine, Beijing, China

  4. 4

    West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese EBM Centre, Chengdu, Sichuan, China

*Guanjian Liu, Department of Evidence-Based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, Sichuan, 610041, China. ceuliu@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 8 OCT 2008

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ling Yan, He Huang, Qi-Zhu Tang, Li-Hua Zhu, Lang Wang, Chen Liu, Zhou-Yan Bian, Hongliang Li, Breviscapine protects against cardiac hypertrophy through blocking PKC-α-dependent signaling, Journal of Cellular Biochemistry, 2010, 109, 6